JAGLX Mutual Fund (Janus Henderson Global Life Sciences Fund Class T) is managed by Janus Henderson Investors with $1.18B in net assets. JAGLX expense ratio is 0.92%, holding 109 positions across sectors including Health Care, Unknown, Other. Inception date: 1998-12-31.

JAGLX performance shows a YTD return of 8.47%. The 1-year return is 39.33% and the 5-year return is 8.40%. JAGLX dividend yield stands at 4.17%, paid annually.

JAGLX top holdings include Eli Lilly And Company (9.7%), JOHNSON AND JOHNSON (5.6%), Astrazeneca Plc Adr (4.3%), Unitedhealth Group, Inc. (3.4%), Abbvie Inc Health Care (3.4%). View all JAGLX holdings, sector breakdown, or dividend history.

JAGLX can be compared against other funds using the overlap calculator or side-by-side comparison tool. JAGLX alternatives are available via the screener, along with tax-loss harvesting opportunities.